Literature DB >> 11677660

When X-ray-inducible proteins meet DNA double strand break repair.

K S Leskov1, T Criswell, S Antonio, J Li, C R Yang, T J Kinsella, D A Boothman.   

Abstract

Cellular responses to ionizing radiation (IR) include (a) activation of signal transduction enzymes; (b) stimulation of DNA repair, most notably DNA double strand break (DSB) repair by homologous or nonhomologous recombinatorial pathways; (c) activation of transcription factors and subsequent IR-inducible transcript and protein changes; (d) cell cycle checkpoint delays in G(1), S, and G(2) required for repair or for programmed cell death of severely damaged cells; (e) activation of zymogens needed for programmed cell death (although IR is a poor inducer of such responses in epithelial cells); and (f) stimulation of IR-inducible proteins that may mediate bystander effects influencing signal transduction, DNA repair, angiogenesis, the immune response, late responses to IR, and possibly adaptive survival responses. The overall response to IR depends on the cell's inherent genetic background, as well as its ability to biochemically and genetically respond to IR-induced damage. To improve the anti-tumor efficacy of IR, our knowledge of these pleiotropic responses must improve. The most important process for the survival of a tumor cell following IR is the repair of DNA double strand breaks (DSBs). Using yeast two-hybrid analyses along with other molecular and cellular biology techniques, we cloned transcripts/proteins that are involved in, or presumably affect, nonhomologous DNA double strand break end-joining (NHEJ) repair mediated by the DNA-PK complex. Using Ku70 as bait, we isolated a number of Ku-binding proteins (KUBs). We identified the first X-ray-inducible transcript/protein (xip8, Clusterin (CLU)) that associates with DNA-PK. A nuclear form of CLU (nCLU) prevented DNA-PK-mediated end joining, and stimulated cell death in response to IR or when overexpressed in the absence of IR. Structure-function analyses using molecular and cellular (including green fluorescence-tagged protein trafficking) biology techniques showed that nCLU appears to be an inactive protein residing in the cytoplasm of epithelial cells. Following IR injury, nCLU levels increase and an as yet undefined posttranslational modification appears to alter the protein, exposing nuclear localization sequences (NLSs) and coiled-coil domains. The modified protein translocates to the nucleus and triggers cell death, presumably through its interaction specifically with Ku70. Understanding nCLU responses, as well as the functions of the KUBs, will be important for understanding DSB repair. Knowledge of DSB repair may be used to improve the antitumor efficacy of IR, as well as other chemotherapeutic agents. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677660     DOI: 10.1053/srao.2001.26912

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  14 in total

1.  Overexpression of truncated AIF regulated by Egr1 promoter radiation-induced apoptosis on MCF-7 cells.

Authors:  Jianfeng Wang; Yana Li; Yang Liu; Yanbo Li; Shouliang Gong; Fang Fang; Zhicheng Wang
Journal:  Radiat Environ Biophys       Date:  2015-10-29       Impact factor: 1.925

Review 2.  Twilight effects of low doses of ionizing radiation on cellular systems: a bird's eye view on current concepts and research.

Authors:  Ilaria Postiglione; Angela Chiaviello; Giuseppe Palumbo
Journal:  Med Oncol       Date:  2009-06-06       Impact factor: 3.064

Review 3.  Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.

Authors:  B Shannan; M Seifert; D A Boothman; W Tilgen; J Reichrath
Journal:  J Mol Histol       Date:  2006-09-19       Impact factor: 2.611

4.  New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.

Authors:  Alessandra Rossi; Silvia Schenone; Adriano Angelucci; Martina Cozzi; Valentina Caracciolo; Francesca Pentimalli; Andrew Puca; Biagio Pucci; Raffaele La Montagna; Mauro Bologna; Maurizio Botta; Antonio Giordano
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

5.  Site-specific integration of Agrobacterium tumefaciens T-DNA via double-stranded intermediates.

Authors:  Tzvi Tzfira; Leah Renée Frankman; Manjusha Vaidya; Vitaly Citovsky
Journal:  Plant Physiol       Date:  2003-10-09       Impact factor: 8.340

6.  The combination of adenoviral HSV TK gene therapy and radiation is effective in athymic mouse glioblastoma xenografts without increasing toxic side effects.

Authors:  Ulf Nestler; Hiroaki Wakimoto; Fernando Siller-Lopez; Laura K Aguilar; Arnab Chakravarti; Alona Muzikansky; Anat Stemmer-Rachamimov; E Antonio Chiocca; Estuardo Aguilar-Cordova; Fred H Hochberg
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

7.  Effects of clusterin over-expression on metastatic progression and therapy in breast cancer.

Authors:  Louise Flanagan; Lorna Whyte; Namita Chatterjee; Martin Tenniswood
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

8.  Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin.

Authors:  Alessandro E Caccamo; Maurizio Scaltriti; Andrea Caporali; Domenico D'Arca; Francesca Scorcioni; Serenella Astancolle; Massimo Mangiola; Saverio Bettuzzi
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

9.  Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences.

Authors:  Jia-Lin Ma; Eun Mi Kim; James E Haber; Sang Eun Lee
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Low-dose radiation and genotoxic chemicals can protect against stochastic biological effects.

Authors:  Bobby R Scott; Dale M Walker; Vernon E Walker
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.